AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This is a Phase I randomized double-blind, placebo-controlled, single and multiple ascending dose study to assess the safety, tolerability and pharmacokinetics of AZD9742 in healthy male and female Japanese subjects

Key facts

Study ID

NCT01114152

Run by

AstraZeneca

People needed

35

Starts

2010-04-01

Expected to finish

2010-07-01

Last updated by the study team

2010-08-03

Who can join

Age: 23 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• female (non-childbearing potential)
• Body mass index (BMI) : 17 to 27 kg/m 2

You may not qualify if…

• History of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject's ability to participate in the study
• History or presence of gastrointestinal, hepatic, or renal disease or any otherHistory or presence of gastrointestinal, hepatic, or renal disease or any other condition known to interfere with absorption, distribution, metabolism, or excretion of drugs
• Any clinically significant illness, medical/surgical procedure, or trauma within 4 weeks of the first administration of investigational product

Where it is running

• Research Site — Glendale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.